Format

Send to

Choose Destination
Clin Nutr. 2013 Jun;32(3):476-8. doi: 10.1016/j.clnu.2012.07.004. Epub 2012 Jul 28.

The sleeve gastrectomy intervention to treat morbid obesity in a Parkinson's disease patient.

Author information

1
Parkinson Institute, Istituti Clinici di Perfezionamento, via Bignami 1, 20126 Milan, Italy.

Erratum in

  • Clin Nutr. 2014 Oct;33(5):928.

Abstract

BACKGROUND & AIMS:

Some Parkinson's disease patients may develop morbid obesity, on account of the reduction in exercise and/or of the appearance of compulsive food intake in the first years after diagnosis. The prescription of central appetite suppressants is actually not recommended in Parkinson's disease patients. To the best of our knowledge, no cases of morbidly obese Parkinson's disease patients submitted to bariatric surgery procedures have been reported in literature before.

METHODS:

We here describe for the first time the outcome of a sleeve gastrectomy intervention in a morbidly obese Parkinson's disease patient, resistant to several non-surgical weight-loss treatments.

RESULTS:

The outcome of the sleeve gastrectomy intervention was satisfactory in terms of body weight-loss, long term weight stabilization and improvement of cardioprotective circulating factors, including adiponectin. Furthermore, the antiparkinson therapy (levodopa) was reduced by 25%.

CONCLUSIONS:

These observations suggest that morbidly obese Parkinson's disease patients, who are resistant to other dietary treatments, might be candidated for sleeve gastrectomy.

PMID:
22841399
DOI:
10.1016/j.clnu.2012.07.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center